T1	Participants 1308 1453	Thirty-seven patients were enrolled, 19 (6 females, median age 43) in the 24 week and 18 (5 females, median age 40) in the 48 week treatment arm.
T2	Participants 1530 1608	12/19 (63%) in the 24 week group and 14/18 (78%) patients in the 48 week group
T3	Participants 1759 1807	10/19 (53%) in the 24 week group and 13/18 (72%)
T4	Participants 1841 1855	Three patients
T5	Participants 1987 2042	9 patients, 4 in the 24 week and 5 in the 48 week group
